Have a feature idea you'd love to see implemented?
Let us know!
SOPH SOPHiA Genetics SA
Price (delayed)
$3.13
Market cap
$207.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.09
Enterprise value
$143.12M
sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and
Highlights
SOPHiA Genetics's revenue has increased by 10% YoY
SOPH's gross profit is up by 8% year-on-year
SOPHiA Genetics's debt has surged by 77% YoY and by 5% QoQ
The company's quick ratio fell by 31% YoY and by 15% QoQ
Key stats
What are the main financial stats of SOPH
Market
Valuations
Earnings
Shares outstanding
66.21M
Market cap
$207.23M
Enterprise value
$143.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.83
Price to sales (P/S)
3.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.22
Revenue
$64.49M
EBIT
-$70.78M
EBITDA
-$62.49M
Free cash flow
-$42.47M
Per share
Balance sheet
Liquidity
EPS
-$1.09
Free cash flow per share
-$0.64
Book value per share
$1.71
Revenue per share
$0.97
TBVPS
$2.22
Total assets
$177.61M
Total liabilities
$64.1M
Debt
$31.67M
Equity
$113.51M
Working capital
$86.34M
Debt to equity
0.28
Current ratio
3.8
Quick ratio
3.42
Net debt/EBITDA
1.03
Margins
Efficiency
Dividend
EBITDA margin
-96.9%
Gross margin
67.8%
Net margin
-110.7%
Operating margin
-105.6%
Return on assets
-38.3%
Return on equity
-55.1%
Return on invested capital
-158.9%
Return on capital employed
-48.2%
Return on sales
-109.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SOPH stock price
How has the SOPHiA Genetics stock price performed over time
Intraday
-1.26%
1 week
-15.41%
1 month
-7.12%
1 year
-18.91%
YTD
-33.55%
QTD
-14.25%
Financial performance
How have SOPHiA Genetics's revenue and profit performed over time
Revenue
$64.49M
Gross profit
$43.73M
Operating income
-$68.07M
Net income
-$71.4M
Gross margin
67.8%
Net margin
-110.7%
The operating margin has grown by 13% YoY
SOPHiA Genetics's revenue has increased by 10% YoY
SOPH's gross profit is up by 8% year-on-year
SOPHiA Genetics's net margin has decreased by 8% QoQ but it has increased by 6% YoY
Growth
What is SOPHiA Genetics's growth rate over time
Valuation
What is SOPHiA Genetics stock price valuation
P/E
N/A
P/B
1.83
P/S
3.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.22
SOPHiA Genetics's EPS has decreased by 7% from the previous quarter
SOPH's equity is down by 28% year-on-year and by 7% since the previous quarter
The P/B is 20% less than the last 4 quarters average of 2.3
The P/S is 30% below the last 4 quarters average of 4.6
SOPHiA Genetics's revenue has increased by 10% YoY
Efficiency
How efficient is SOPHiA Genetics business performance
SOPHiA Genetics's ROE has decreased by 43% YoY and by 16% from the previous quarter
The ROA has declined by 26% year-on-year and by 11% since the previous quarter
SOPHiA Genetics's ROS has decreased by 8% from the previous quarter but it has increased by 6% YoY
Dividends
What is SOPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SOPH.
Financial health
How did SOPHiA Genetics financials performed over time
SOPH's total assets is 177% greater than its total liabilities
The total liabilities has grown by 35% YoY and by 7% from the previous quarter
The company's quick ratio fell by 31% YoY and by 15% QoQ
SOPHiA Genetics's debt is 72% lower than its equity
The debt to equity has soared by 155% year-on-year and by 12% since the previous quarter
SOPHiA Genetics's debt has surged by 77% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.